Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Summary

This phase I/II trial studies the side effects and best dose of temsirolimus when given together with perifosine and to see how well it works in treating patients with recurrent or progressive malignant glioma. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as perifosine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving temsirolimus with perifosine may be an effective treatment for malignant glioma.

Timeline

Start

2010-01-27

Primary completion

2018-11-16

Completion

2020-09-30

Drugs

Indications